Tag: Emergency Use List
Covaxin P3 data published in Lancet, overall 77.8% efficacy confirmed
This first publication of the data shows COVAXIN has 93.4% efficacy against severe COVID-19 disease, 77.8% overall efficacy, 63.6% efficacy against asymptomatic disease and 65.2% efficacy against the Delta variant in the Phase 3 clinical trial of 25,798 participants..........................